Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Ionis Pharmaceuticals Inc Share Price

IONS

NSQ

$82.705

+$0.03

(0.04%)

Industry: Biotechnology Sector: Health Care

Ionis Pharmaceuticals Inc Analyst Forecast

Overview Returns Financials Ratios News FAQs

Ionis Pharmaceuticals Inc Share Price Chart

Ionis Pharmaceuticals Inc Key Stock Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$13.39B

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

Volume

This is the total number of shares traded during the most recent trading day.

325.30K

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

0.28

52-week Range info-icon

This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$23.95 L

$86.15 H

$82.705

About Ionis Pharmaceuticals Inc, Common Stock

Ionis Pharmaceuticals, Inc., a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States. The company offers TRYNGOLZA reduces triglyceride levels in adults with familial chylomicronemia syndrome (FCS) and acute pancreatitis; WAINUA for the treatment of the polyneuropathy of hereditary transthyretin-medicated amyloidosis (ATTRv-PN) in adults; and SPINRAZA for pediatric and adult patients with spinal muscular atrophy (SMA). It also provides QALSODY for the treatment of Amyotrophic Lateral Sclerosis (ALS); TEGSEDI for the treatment of ATTRv-PN in adults; and WAYLIVRA for treatment for FCS and familial partial lipodystrophy. It also develops products under Phase 3 clinical trials, such as Olezarsen for patients with hypertriglyceridemia (SHTG) and cardiovascular disease (CVD); Donidalorsen for patients with hereditary angioedema; and Zilganerse, a potential treatment for people with genetically confirmed Alexander disease, as well as ION582 that has completed Phase 2 clinical trial for the potential treatment of AS, a rare genetic neurological disease. In addition, the company develops Eplontersen to degrade mutant and wild-type TTR mRNA through binding to the TTR mRNA; Pelacarsen to inhibit the production of apolipoprotein(a) in the liver to offer a direct approach for reducing lipoprotein(a); Bepirovirsen to inhibit the production of viral proteins associated with hepatitis B virus; Sefaxersen to reduce the production of complement factor B and lower activation of the alternative complement pathway; and Ulefnersen to reduce the production of the fused in sarcoma, as well as other mid-stage pipeline investigational medicines. It has a strategic collaboration with Biogen for the treatment of neurological disorders; and collaboration and license agreement with GSK, AstraZeneca, Novartis, and Roche, as well as with Metagenomi. The company was incorporated in 1989 and is headquartered in Carlsbad, California. more

Industry: BiotechnologySector: Health Care

Ionis Pharmaceuticals Inc Stock Returns

Time Frame	IONS	Sector	S&P500
1-Week Return	2.97%	-1.74%	0.38%
1-Month Return	4.69%	-0.6%	0.71%
3-Month Return	11.46%	7.23%	1.76%
6-Month Return	90.62%	15.31%	9.09%
1-Year Return	148.11%	5.02%	14.37%
3-Year Return	110.68%	17.53%	72.79%
5-Year Return	40.19%	34.01%	84%
10-Year Return	110.46%	132.45%	258.25%

Time Frame	IONS	Sector	S&P500
1-Week Return	360.02%	-59.96%	21.87%
1-Month Return	74.65%	-7.06%	8.99%
3-Month Return	55.27%	32.72%	7.33%
6-Month Return	269.93%	33.49%	19.29%
1-Year Return	148.11%	5.02%	14.37%
3-Year Return	28.20%	5.53%	20.00%
5-Year Return	6.99%	6.03%	12.97%
10-Year Return	7.73%	8.80%	13.61%

Ionis Pharmaceuticals Inc Financials

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Revenue	729.00M	810.46M	587.37M	787.65M	705.14M	[{"date":"2020-12-31","value":89.95,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":72.47,"profit":true},{"date":"2023-12-31","value":97.19,"profit":true},{"date":"2024-12-31","value":87.01,"profit":true}]
Cost of Revenue	12.00M	10.84M	14.12M	9.13M	11.21M	[{"date":"2020-12-31","value":85.01,"profit":true},{"date":"2021-12-31","value":76.81,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":64.7,"profit":true},{"date":"2024-12-31","value":79.45,"profit":true}]
Gross Profit	717.00M	799.61M	573.25M	778.51M	693.92M	[{"date":"2020-12-31","value":89.67,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":71.69,"profit":true},{"date":"2023-12-31","value":97.36,"profit":true},{"date":"2024-12-31","value":86.78,"profit":true}]
Gross Margin	98.35%	98.66%	97.60%	98.84%	98.41%	[{"date":"2020-12-31","value":99.51,"profit":true},{"date":"2021-12-31","value":99.82,"profit":true},{"date":"2022-12-31","value":98.74,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":99.56,"profit":true}]

Operating Expenses	889.00M	829.80M	983.44M	1.13B	1.17B	[{"date":"2020-12-31","value":76.05,"profit":true},{"date":"2021-12-31","value":70.98,"profit":true},{"date":"2022-12-31","value":84.13,"profit":true},{"date":"2023-12-31","value":96.86,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income	(172.00M)	(30.19M)	(410.19M)	(353.73M)	(475.08M)	[{"date":"2020-12-31","value":-17200000000,"profit":false},{"date":"2021-12-31","value":-3018600000,"profit":false},{"date":"2022-12-31","value":-41019100000,"profit":false},{"date":"2023-12-31","value":-35373000000,"profit":false},{"date":"2024-12-31","value":-47508100000,"profit":false}]
Total Non-Operating Income/Expense	(42.99M)	(8.16M)	144.08M	(61.73M)	(75.44M)	[{"date":"2020-12-31","value":-29.84,"profit":false},{"date":"2021-12-31","value":-5.66,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-42.84,"profit":false},{"date":"2024-12-31","value":-52.36,"profit":false}]
Pre-Tax Income	(170.00M)	(29.15M)	(257.99M)	(333.96M)	(460.07M)	[{"date":"2020-12-31","value":-17000000000,"profit":false},{"date":"2021-12-31","value":-2914800000,"profit":false},{"date":"2022-12-31","value":-25798500000,"profit":false},{"date":"2023-12-31","value":-33396500000,"profit":false},{"date":"2024-12-31","value":-46006800000,"profit":false}]
Income Taxes	317.00M	(551.00K)	11.74M	32.32M	(6.17M)	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-0.17,"profit":false},{"date":"2022-12-31","value":3.7,"profit":true},{"date":"2023-12-31","value":10.2,"profit":true},{"date":"2024-12-31","value":-1.95,"profit":false}]
Income After Taxes	(487.00M)	(28.60M)	(269.72M)	(366.29M)	(453.90M)	[{"date":"2020-12-31","value":-48700000000,"profit":false},{"date":"2021-12-31","value":-2859700000,"profit":false},{"date":"2022-12-31","value":-26972200000,"profit":false},{"date":"2023-12-31","value":-36628600000,"profit":false},{"date":"2024-12-31","value":-45389700000,"profit":false}]

Income From Continuous Operations	(486.77M)	(28.60M)	(269.72M)	(366.29M)	(453.90M)	[{"date":"2020-12-31","value":-48676600000,"profit":false},{"date":"2021-12-31","value":-2859700000,"profit":false},{"date":"2022-12-31","value":-26972200000,"profit":false},{"date":"2023-12-31","value":-36628600000,"profit":false},{"date":"2024-12-31","value":-45389700000,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	(487.00M)	(28.60M)	(269.72M)	(366.29M)	(453.90M)	[{"date":"2020-12-31","value":-48700000000,"profit":false},{"date":"2021-12-31","value":-2859700000,"profit":false},{"date":"2022-12-31","value":-26972200000,"profit":false},{"date":"2023-12-31","value":-36628600000,"profit":false},{"date":"2024-12-31","value":-45389700000,"profit":false}]

EPS (Diluted)	(0.36)	(0.38)	(2.89)	(2.56)	(2.81)	[{"date":"2020-12-31","value":-36,"profit":false},{"date":"2021-12-31","value":-38,"profit":false},{"date":"2022-12-31","value":-289,"profit":false},{"date":"2023-12-31","value":-256,"profit":false},{"date":"2024-12-31","value":-281.04,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Revenue	-	11.17%	(27.53%)	34.10%	(10.48%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":32.77,"profit":true},{"date":"2022-12-31","value":-80.73,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-30.72,"profit":false}]
Cost of Revenue	-	(9.65%)	30.20%	(35.30%)	22.80%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-31.96,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-116.9,"profit":false},{"date":"2024-12-31","value":75.49,"profit":true}]
Gross Profit	-	11.52%	(28.31%)	35.81%	(10.87%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":32.18,"profit":true},{"date":"2022-12-31","value":-79.06,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-30.35,"profit":false}]
Gross Margin	-	0.31%	(1.08%)	1.27%	(0.44%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":24.6,"profit":true},{"date":"2022-12-31","value":-84.74,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-34.21,"profit":false}]

Operating Expenses	-	(6.66%)	18.52%	15.13%	3.25%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-35.97,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":81.72,"profit":true},{"date":"2024-12-31","value":17.53,"profit":true}]
Operating Income	-	(82.45%)	1258.88%	(13.76%)	34.31%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-6.55,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-1.09,"profit":false},{"date":"2024-12-31","value":2.73,"profit":true}]
Total Non-Operating Income/Expense	-	(81.01%)	(1865.30%)	(142.84%)	22.21%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-364.73,"profit":false},{"date":"2022-12-31","value":-8397.67,"profit":false},{"date":"2023-12-31","value":-643.09,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income	-	(82.85%)	785.09%	29.45%	37.76%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-10.55,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":3.75,"profit":true},{"date":"2024-12-31","value":4.81,"profit":true}]
Income Taxes	-	(100.17%)	(2230.13%)	175.38%	(119.09%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-57.12,"profit":false},{"date":"2022-12-31","value":-1271.62,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-67.91,"profit":false}]
Income After Taxes	-	(94.13%)	843.18%	35.80%	23.92%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-11.16,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":4.25,"profit":true},{"date":"2024-12-31","value":2.84,"profit":true}]

Income From Continuous Operations	-	(94.13%)	843.18%	35.80%	23.92%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-11.16,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":4.25,"profit":true},{"date":"2024-12-31","value":2.84,"profit":true}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	-	(94.13%)	843.18%	35.80%	23.92%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-11.16,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":4.25,"profit":true},{"date":"2024-12-31","value":2.84,"profit":true}]

EPS (Diluted)	-	5.56%	660.53%	(11.42%)	9.78%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":0.84,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-1.73,"profit":false},{"date":"2024-12-31","value":1.48,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Revenue	133.81M	226.58M	131.61M	452.05M	156.72M	[{"date":"2024-09-30","value":29.6,"profit":true},{"date":"2024-12-31","value":50.12,"profit":true},{"date":"2025-03-31","value":29.11,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":34.67,"profit":true}]
Cost of Revenue	1.07M	3.83M	1.50M	4.15M	2.34M	[{"date":"2024-09-30","value":25.8,"profit":true},{"date":"2024-12-31","value":92.27,"profit":true},{"date":"2025-03-31","value":36.14,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":56.32,"profit":true}]
Gross Profit	132.74M	222.75M	130.11M	447.90M	154.38M	[{"date":"2024-09-30","value":29.64,"profit":true},{"date":"2024-12-31","value":49.73,"profit":true},{"date":"2025-03-31","value":29.05,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":34.47,"profit":true}]
Gross Margin	99.20%	98.31%	98.86%	99.08%	98.51%	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":99.1,"profit":true},{"date":"2025-03-31","value":99.66,"profit":true},{"date":"2025-06-30","value":99.88,"profit":true},{"date":"2025-09-30","value":99.3,"profit":true}]

Operating Expenses	281.40M	333.57M	276.97M	308.08M	314.56M	[{"date":"2024-09-30","value":84.36,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":83.03,"profit":true},{"date":"2025-06-30","value":92.36,"profit":true},{"date":"2025-09-30","value":94.3,"profit":true}]
Operating Income	(148.66M)	(110.82M)	(146.86M)	139.82M	(160.18M)	[{"date":"2024-09-30","value":-106.32,"profit":false},{"date":"2024-12-31","value":-79.26,"profit":false},{"date":"2025-03-31","value":-105.04,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-114.57,"profit":false}]
Total Non-Operating Income/Expense	(18.18M)	(19.09M)	(22.88M)	(39.03M)	9.64M	[{"date":"2024-09-30","value":-188.63,"profit":false},{"date":"2024-12-31","value":-198.04,"profit":false},{"date":"2025-03-31","value":-237.46,"profit":false},{"date":"2025-06-30","value":-405.03,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]
Pre-Tax Income	(144.10M)	(107.04M)	(146.82M)	123.53M	(128.39M)	[{"date":"2024-09-30","value":-116.65,"profit":false},{"date":"2024-12-31","value":-86.65,"profit":false},{"date":"2025-03-31","value":-118.85,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-103.94,"profit":false}]
Income Taxes	(3.62M)	(2.69M)	116.00K	(20.00K)	213.00K	[{"date":"2024-09-30","value":-1700,"profit":false},{"date":"2024-12-31","value":-1262.91,"profit":false},{"date":"2025-03-31","value":54.46,"profit":true},{"date":"2025-06-30","value":-9.39,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]
Income After Taxes	(140.48M)	(104.35M)	(146.94M)	123.55M	(128.61M)	[{"date":"2024-09-30","value":-113.7,"profit":false},{"date":"2024-12-31","value":-84.46,"profit":false},{"date":"2025-03-31","value":-118.93,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-104.09,"profit":false}]

Income From Continuous Operations	(140.48M)	(104.35M)	(146.94M)	123.55M	(128.61M)	[{"date":"2024-09-30","value":-113.7,"profit":false},{"date":"2024-12-31","value":-84.46,"profit":false},{"date":"2025-03-31","value":-118.93,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-104.09,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Net Income	(140.48M)	(104.35M)	(146.94M)	123.55M	(128.61M)	[{"date":"2024-09-30","value":-113.7,"profit":false},{"date":"2024-12-31","value":-84.46,"profit":false},{"date":"2025-03-31","value":-118.93,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-104.09,"profit":false}]

EPS (Diluted)	(0.95)	(0.43)	(0.92)	0.70	(0.80)	[{"date":"2024-09-30","value":-135.71,"profit":false},{"date":"2024-12-31","value":-61.49,"profit":false},{"date":"2025-03-31","value":-132.07,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-114.29,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Revenue	-	69.32%	(41.91%)	243.47%	(65.33%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":28.47,"profit":true},{"date":"2025-03-31","value":-17.21,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-26.83,"profit":false}]
Cost of Revenue	-	257.61%	(60.84%)	176.73%	(43.68%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-23.62,"profit":false},{"date":"2025-06-30","value":68.61,"profit":true},{"date":"2025-09-30","value":-16.95,"profit":false}]
Gross Profit	-	67.80%	(41.59%)	244.24%	(65.53%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":27.76,"profit":true},{"date":"2025-03-31","value":-17.03,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-26.83,"profit":false}]
Gross Margin	-	(0.90%)	0.56%	0.22%	(0.58%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-160.17,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":39.99,"profit":true},{"date":"2025-09-30","value":-103.35,"profit":false}]

Operating Expenses	-	18.54%	(16.97%)	11.23%	2.10%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-91.52,"profit":false},{"date":"2025-06-30","value":60.59,"profit":true},{"date":"2025-09-30","value":11.35,"profit":true}]
Operating Income	-	(25.45%)	32.52%	(195.20%)	(214.57%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-78.27,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-600.3,"profit":false},{"date":"2025-09-30","value":-659.85,"profit":false}]
Total Non-Operating Income/Expense	-	4.99%	19.91%	70.57%	(124.69%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":7.07,"profit":true},{"date":"2025-03-31","value":28.21,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-176.69,"profit":false}]
Pre-Tax Income	-	(25.72%)	37.17%	(184.14%)	(203.94%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-69.2,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-495.43,"profit":false},{"date":"2025-09-30","value":-548.7,"profit":false}]
Income Taxes	-	(25.71%)	(104.31%)	(117.24%)	(1165.00%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]
Income After Taxes	-	(25.72%)	40.81%	(184.08%)	(204.09%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-63.02,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-451.03,"profit":false},{"date":"2025-09-30","value":-500.05,"profit":false}]

Income From Continuous Operations	-	(25.72%)	40.81%	(184.08%)	(204.09%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-63.02,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-451.03,"profit":false},{"date":"2025-09-30","value":-500.05,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Net Income	-	(25.72%)	40.81%	(184.08%)	(204.09%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-63.02,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-451.03,"profit":false},{"date":"2025-09-30","value":-500.05,"profit":false}]

EPS (Diluted)	-	(54.69%)	114.80%	(175.72%)	(214.29%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-47.64,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-153.06,"profit":false},{"date":"2025-09-30","value":-186.66,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Assets
Current Assets	2.13B	2.35B	2.20B	2.64B	2.62B	[{"date":"2020-12-31","value":80.63,"profit":true},{"date":"2021-12-31","value":88.76,"profit":true},{"date":"2022-12-31","value":83.38,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":99.18,"profit":true}]
Non-current Assets	260.00M	267.00M	331.18M	348.22M	383.38M	[{"date":"2020-12-31","value":67.82,"profit":true},{"date":"2021-12-31","value":69.64,"profit":true},{"date":"2022-12-31","value":86.38,"profit":true},{"date":"2023-12-31","value":90.83,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Assets	2.39B	2.61B	2.53B	2.99B	3.00B	[{"date":"2020-12-31","value":79.57,"profit":true},{"date":"2021-12-31","value":86.96,"profit":true},{"date":"2022-12-31","value":84.36,"profit":true},{"date":"2023-12-31","value":99.55,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Liabilities
Current Liabilities	290.00M	241.00M	311.56M	448.09M	309.32M	[{"date":"2020-12-31","value":64.72,"profit":true},{"date":"2021-12-31","value":53.78,"profit":true},{"date":"2022-12-31","value":69.53,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":69.03,"profit":true}]
Non-current Liabilities	1.26B	1.60B	1.65B	2.16B	2.11B	[{"date":"2020-12-31","value":58.32,"profit":true},{"date":"2021-12-31","value":74.19,"profit":true},{"date":"2022-12-31","value":76.53,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":97.71,"profit":true}]
Total Liabilities	1.55B	1.84B	1.96B	2.60B	2.42B	[{"date":"2020-12-31","value":59.42,"profit":true},{"date":"2021-12-31","value":70.68,"profit":true},{"date":"2022-12-31","value":75.32,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":92.78,"profit":true}]

Total Shareholders' equity
Common Stock	140.00K	141.00K	142.00K	144.00K	158.00K	[{"date":"2020-12-31","value":88.61,"profit":true},{"date":"2021-12-31","value":89.24,"profit":true},{"date":"2022-12-31","value":89.87,"profit":true},{"date":"2023-12-31","value":91.14,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Retained Earnings	(1.25B)	(1.16B)	(1.43B)	(1.80B)	(2.25B)	[{"date":"2020-12-31","value":-124936800000,"profit":false},{"date":"2021-12-31","value":-115990300000,"profit":false},{"date":"2022-12-31","value":-142962500000,"profit":false},{"date":"2023-12-31","value":-179591100000,"profit":false},{"date":"2024-12-31","value":-224980800000,"profit":false}]
Other Stockholders' Equity	2.11B	1.96B	2.06B	2.22B	2.87B	[{"date":"2020-12-31","value":73.66,"profit":true},{"date":"2021-12-31","value":68.48,"profit":true},{"date":"2022-12-31","value":71.8,"profit":true},{"date":"2023-12-31","value":77.21,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Shareholders' equity	843.00M	772.00M	572.89M	386.69M	588.35M	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":91.58,"profit":true},{"date":"2022-12-31","value":67.96,"profit":true},{"date":"2023-12-31","value":45.87,"profit":true},{"date":"2024-12-31","value":69.79,"profit":true}]

Total Liabilities & Shareholders Equity	2.39B	2.61B	2.53B	2.99B	3.00B	[{"date":"2020-12-31","value":79.57,"profit":true},{"date":"2021-12-31","value":86.96,"profit":true},{"date":"2022-12-31","value":84.36,"profit":true},{"date":"2023-12-31","value":99.55,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Assets
Current Assets	-	10.09%	(6.07%)	19.94%	(0.82%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":50.63,"profit":true},{"date":"2022-12-31","value":-30.44,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-4.09,"profit":false}]
Non-current Assets	-	2.69%	24.04%	5.14%	10.10%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":11.2,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":21.4,"profit":true},{"date":"2024-12-31","value":42.01,"profit":true}]
Total Assets	-	9.29%	(2.99%)	18.00%	0.45%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":51.59,"profit":true},{"date":"2022-12-31","value":-16.61,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":2.53,"profit":true}]

Total Liabilities
Current Liabilities	-	(16.90%)	29.28%	43.82%	(30.97%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-38.56,"profit":false},{"date":"2022-12-31","value":66.81,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-70.67,"profit":false}]
Non-current Liabilities	-	27.21%	3.15%	30.67%	(2.29%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":88.71,"profit":true},{"date":"2022-12-31","value":10.28,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-7.46,"profit":false}]
Total Liabilities	-	18.94%	6.58%	32.76%	(7.22%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":57.82,"profit":true},{"date":"2022-12-31","value":20.07,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-22.05,"profit":false}]

Total Shareholders' equity
Common Stock	-	0.71%	0.71%	1.41%	9.72%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":7.35,"profit":true},{"date":"2022-12-31","value":7.29,"profit":true},{"date":"2023-12-31","value":14.49,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Retained Earnings	-	(7.16%)	23.25%	25.62%	25.27%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-27.95,"profit":false},{"date":"2022-12-31","value":90.76,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":98.64,"profit":true}]
Other Stockholders' Equity	-	(7.04%)	4.86%	7.54%	29.51%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-23.87,"profit":false},{"date":"2022-12-31","value":16.46,"profit":true},{"date":"2023-12-31","value":25.54,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Shareholders' equity	-	(8.42%)	(25.79%)	(32.50%)	52.15%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-16.15,"profit":false},{"date":"2022-12-31","value":-49.46,"profit":false},{"date":"2023-12-31","value":-62.32,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	-	9.29%	(2.99%)	18.00%	0.45%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":51.59,"profit":true},{"date":"2022-12-31","value":-16.61,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":2.53,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Assets
Current Assets	2.71B	2.62B	2.42B	2.58B	2.52B	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":96.55,"profit":true},{"date":"2025-03-31","value":89.13,"profit":true},{"date":"2025-06-30","value":94.96,"profit":true},{"date":"2025-09-30","value":92.82,"profit":true}]
Non-current Assets	367.25M	383.38M	394.02M	407.98M	514.10M	[{"date":"2024-09-30","value":71.44,"profit":true},{"date":"2024-12-31","value":74.57,"profit":true},{"date":"2025-03-31","value":76.64,"profit":true},{"date":"2025-06-30","value":79.36,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Total Assets	3.08B	3.00B	2.81B	2.99B	3.03B	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":97.49,"profit":true},{"date":"2025-03-31","value":91.3,"profit":true},{"date":"2025-06-30","value":96.89,"profit":true},{"date":"2025-09-30","value":98.44,"profit":true}]

Total Liabilities
Current Liabilities	304.57M	309.32M	250.29M	897.24M	903.46M	[{"date":"2024-09-30","value":33.71,"profit":true},{"date":"2024-12-31","value":34.24,"profit":true},{"date":"2025-03-31","value":27.7,"profit":true},{"date":"2025-06-30","value":99.31,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Non-current Liabilities	2.11B	2.11B	2.09B	1.46B	1.51B	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":99.62,"profit":true},{"date":"2025-03-31","value":98.72,"profit":true},{"date":"2025-06-30","value":68.88,"profit":true},{"date":"2025-09-30","value":71.51,"profit":true}]
Total Liabilities	2.42B	2.42B	2.34B	2.35B	2.42B	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":99.86,"profit":true},{"date":"2025-03-31","value":96.63,"profit":true},{"date":"2025-06-30","value":97.3,"profit":true},{"date":"2025-09-30","value":99.86,"profit":true}]

Total Shareholders' equity
Common Stock	158.00K	158.00K	159.00K	159.00K	161.00K	[{"date":"2024-09-30","value":98.14,"profit":true},{"date":"2024-12-31","value":98.14,"profit":true},{"date":"2025-03-31","value":98.76,"profit":true},{"date":"2025-06-30","value":98.76,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Retained Earnings	(2.15B)	(2.25B)	(2.40B)	(2.27B)	(2.40B)	[{"date":"2024-09-30","value":-214545900000,"profit":false},{"date":"2024-12-31","value":-224980800000,"profit":false},{"date":"2025-03-31","value":-239674600000,"profit":false},{"date":"2025-06-30","value":-227319500000,"profit":false},{"date":"2025-09-30","value":-240180100000,"profit":false}]
Other Stockholders' Equity	2.83B	2.87B	2.90B	2.93B	3.05B	[{"date":"2024-09-30","value":92.99,"profit":true},{"date":"2024-12-31","value":94.2,"profit":true},{"date":"2025-03-31","value":95.26,"profit":true},{"date":"2025-06-30","value":96.3,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Total Shareholders' equity	662.47M	588.35M	475.73M	631.72M	617.97M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":88.81,"profit":true},{"date":"2025-03-31","value":71.81,"profit":true},{"date":"2025-06-30","value":95.36,"profit":true},{"date":"2025-09-30","value":93.28,"profit":true}]

Total Liabilities & Shareholders Equity	3.08B	3.00B	2.81B	2.99B	3.03B	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":97.49,"profit":true},{"date":"2025-03-31","value":91.3,"profit":true},{"date":"2025-06-30","value":96.89,"profit":true},{"date":"2025-09-30","value":98.44,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Assets
Current Assets	-	(3.45%)	(7.68%)	6.54%	(2.26%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-52.71,"profit":false},{"date":"2025-03-31","value":-117.49,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-34.5,"profit":false}]
Non-current Assets	-	4.39%	2.77%	3.54%	26.01%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":16.89,"profit":true},{"date":"2025-03-31","value":10.66,"profit":true},{"date":"2025-06-30","value":13.63,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Total Assets	-	(2.51%)	(6.35%)	6.12%	1.61%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-41.05,"profit":false},{"date":"2025-03-31","value":-103.74,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":26.25,"profit":true}]

Total Liabilities
Current Liabilities	-	1.56%	(19.08%)	258.47%	0.69%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":0.6,"profit":true},{"date":"2025-03-31","value":-7.38,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":0.27,"profit":true}]
Non-current Liabilities	-	(0.38%)	(0.91%)	(30.22%)	3.81%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-10,"profit":false},{"date":"2025-03-31","value":-23.77,"profit":false},{"date":"2025-06-30","value":-793.07,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]
Total Liabilities	-	(0.14%)	(3.23%)	0.69%	2.62%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-5.21,"profit":false},{"date":"2025-03-31","value":-123.31,"profit":false},{"date":"2025-06-30","value":26.41,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	0.63%	-	1.26%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":50.32,"profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Retained Earnings	-	4.86%	6.53%	(5.15%)	5.66%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":74.47,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-78.93,"profit":false},{"date":"2025-09-30","value":86.62,"profit":true}]
Other Stockholders' Equity	-	1.30%	1.13%	1.09%	3.85%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":33.84,"profit":true},{"date":"2025-03-31","value":29.4,"profit":true},{"date":"2025-06-30","value":28.21,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Total Shareholders' equity	-	(11.19%)	(19.14%)	32.79%	(2.18%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-34.12,"profit":false},{"date":"2025-03-31","value":-58.38,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-6.64,"profit":false}]

Total Liabilities & Shareholders Equity	-	(2.51%)	(6.35%)	6.12%	1.61%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-41.05,"profit":false},{"date":"2025-03-31","value":-103.74,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":26.25,"profit":true}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Operating Activities
Net Operating Cash Flow	35.89M	30.80M	(274.37M)	(307.51M)	(500.95M)	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":85.81,"profit":true},{"date":"2022-12-31","value":-764.43,"profit":false},{"date":"2023-12-31","value":-856.77,"profit":false},{"date":"2024-12-31","value":-1395.71,"profit":false}]

Investing Activities
Net Investing Cash Flow	274.48M	194.91M	(262.64M)	(214.13M)	(134.03M)	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":71.01,"profit":true},{"date":"2022-12-31","value":-95.69,"profit":false},{"date":"2023-12-31","value":-78.01,"profit":false},{"date":"2024-12-31","value":-48.83,"profit":false}]

Financing Activities
Net Financing Cash Flow	(596.61M)	245.93M	(55.30M)	644.08M	478.06M	[{"date":"2020-12-31","value":-92.63,"profit":false},{"date":"2021-12-31","value":38.18,"profit":true},{"date":"2022-12-31","value":-8.59,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":74.22,"profit":true}]

Net Change in Cash	(285.62M)	471.53M	(592.72M)	122.79M	(157.19M)	[{"date":"2020-12-31","value":-60.57,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-125.7,"profit":false},{"date":"2023-12-31","value":26.04,"profit":true},{"date":"2024-12-31","value":-33.34,"profit":false}]

Free Cash Flow
Free Cash Flow	(5.16M)	12.90M	(294.47M)	(335.52M)	(546.23M)	[{"date":"2020-12-31","value":-39.98,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-2283.06,"profit":false},{"date":"2023-12-31","value":-2601.36,"profit":false},{"date":"2024-12-31","value":-4234.97,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Operating Activities
Net Operating Cash Flow	-	(14.19%)	(990.84%)	12.08%	62.90%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-22.56,"profit":false},{"date":"2022-12-31","value":-1575.2,"profit":false},{"date":"2023-12-31","value":19.2,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	(28.99%)	(234.75%)	(18.47%)	(37.41%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]

Financing Activities
Net Financing Cash Flow	-	(141.22%)	(122.48%)	(1264.81%)	(25.78%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]

Net Change in Cash	-	(265.09%)	(225.70%)	(120.72%)	(228.01%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]

Free Cash Flow
Free Cash Flow	-	(350.16%)	(2383.06%)	13.94%	62.80%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-557.59,"profit":false},{"date":"2022-12-31","value":-3794.79,"profit":false},{"date":"2023-12-31","value":22.2,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Operating Activities
Net Operating Cash Flow	(114.99M)	(116.14M)	(150.78M)	151.34M	(131.44M)	[{"date":"2024-09-30","value":-75.98,"profit":false},{"date":"2024-12-31","value":-76.74,"profit":false},{"date":"2025-03-31","value":-99.63,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-86.85,"profit":false}]

Investing Activities
Net Investing Cash Flow	(340.80M)	68.21M	170.46M	(120.07M)	91.34M	[{"date":"2024-09-30","value":-199.93,"profit":false},{"date":"2024-12-31","value":40.02,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-70.44,"profit":false},{"date":"2025-09-30","value":53.58,"profit":true}]

Financing Activities
Net Financing Cash Flow	496.05M	(44.12M)	2.20M	1.25M	81.22M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":-8.89,"profit":false},{"date":"2025-03-31","value":0.44,"profit":true},{"date":"2025-06-30","value":0.25,"profit":true},{"date":"2025-09-30","value":16.37,"profit":true}]

Net Change in Cash	40.61M	(92.53M)	22.11M	33.11M	41.04M	[{"date":"2024-09-30","value":98.96,"profit":true},{"date":"2024-12-31","value":-225.47,"profit":false},{"date":"2025-03-31","value":53.89,"profit":true},{"date":"2025-06-30","value":80.69,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Free Cash Flow
Free Cash Flow	(124.05M)	(141.64M)	(163.35M)	137.07M	(134.74M)	[{"date":"2024-09-30","value":-90.5,"profit":false},{"date":"2024-12-31","value":-103.33,"profit":false},{"date":"2025-03-31","value":-119.18,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-98.3,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Operating Activities
Net Operating Cash Flow	-	1.00%	29.82%	(200.37%)	(186.85%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":3.35,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-671.88,"profit":false},{"date":"2025-09-30","value":-626.53,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	(120.02%)	149.89%	(170.44%)	(176.07%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-80.07,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-113.71,"profit":false},{"date":"2025-09-30","value":-117.47,"profit":false}]

Financing Activities
Net Financing Cash Flow	-	(108.89%)	(104.98%)	(43.29%)	6413.07%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-1.7,"profit":false},{"date":"2025-03-31","value":-1.64,"profit":false},{"date":"2025-06-30","value":-0.68,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

Net Change in Cash	-	(327.83%)	(123.90%)	49.73%	23.93%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-659.28,"profit":false},{"date":"2025-03-31","value":-249.17,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":48.13,"profit":true}]

Free Cash Flow
Free Cash Flow	-	14.18%	15.33%	(183.91%)	(198.30%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":92.49,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-1199.5,"profit":false},{"date":"2025-09-30","value":-1293.37,"profit":false}]

Ionis Pharmaceuticals Inc Ratios

Ionis Pharmaceuticals Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

	IONS
Cash Ratio	2.48
Current Ratio	2.79
Quick Ratio	2.78

Ionis Pharmaceuticals Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	IONS
ROA (LTM)	-5.68%
ROE (LTM)	-40.04%

Ionis Pharmaceuticals Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	IONS
Debt Ratio Lower is generally better. Negative is bad.	0.80
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	0.20

Ionis Pharmaceuticals Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	IONS
Trailing PE	NM
Forward PE	90.91
P/S (TTM)	13.88
P/B	21.99
Price/FCF	NM
EV/R	13.27
EV/Ebitda	NM
PEG	25.70

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is Ionis Pharmaceuticals Inc share price today?

Ionis Pharmaceuticals Inc (IONS) share price today is $82.705

Can Indians buy Ionis Pharmaceuticals Inc shares?

Yes, Indians can buy shares of Ionis Pharmaceuticals Inc (IONS) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in IONS stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Ionis Pharmaceuticals Inc be purchased?

Yes, you can purchase fractional shares of Ionis Pharmaceuticals Inc (IONS) via the Vested app. You can start investing in Ionis Pharmaceuticals Inc (IONS) with a minimum investment of $1.

How to invest in Ionis Pharmaceuticals Inc shares from India?

You can invest in shares of Ionis Pharmaceuticals Inc (IONS) via Vested in three simple steps:

Click on Sign Up or Invest in IONS stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in Ionis Pharmaceuticals Inc shares

What is Ionis Pharmaceuticals Inc 52-week high and low stock price?

The 52-week high price of Ionis Pharmaceuticals Inc (IONS) is $86.15. The 52-week low price of Ionis Pharmaceuticals Inc (IONS) is $23.95.

What is Ionis Pharmaceuticals Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Ionis Pharmaceuticals Inc (IONS) is

What is Ionis Pharmaceuticals Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Ionis Pharmaceuticals Inc (IONS) is 21.99

What is Ionis Pharmaceuticals Inc dividend yield?

The dividend yield of Ionis Pharmaceuticals Inc (IONS) is 0.00%

What is the Market Cap of Ionis Pharmaceuticals Inc?

The market capitalization of Ionis Pharmaceuticals Inc (IONS) is $13.39B

What is Ionis Pharmaceuticals Inc's stock symbol?

The stock symbol (or ticker) of Ionis Pharmaceuticals Inc is IONS

How Can Investors Use Ionis Pharmaceuticals Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Ionis Pharmaceuticals Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Ionis Pharmaceuticals Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Ionis Pharmaceuticals Inc shares for Indian investors?

When investing in Ionis Pharmaceuticals Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Ionis Pharmaceuticals Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Ionis Pharmaceuticals Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Ionis Pharmaceuticals Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Ionis Pharmaceuticals Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Feedback

Request to add more info/data

Inform about wrong info/data

Link copied

Signup to access all features and start your US investing journey!

Open your account in minutes
Take your portfolio global, starting at just $1

Get started

Add ticker to compare

Apple, Inc AAPL
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

Ionis Pharmaceuticals Inc Share Price

Ionis Pharmaceuticals Inc Analyst Forecast

Ionis Pharmaceuticals Inc Share Price Chart

Ionis Pharmaceuticals Inc Key Stock Metrics

About Ionis Pharmaceuticals Inc, Common Stock

Ionis Pharmaceuticals Inc Stock Returns

Ionis Pharmaceuticals Inc Financials

Ionis Pharmaceuticals Inc Ratios

Ionis Pharmaceuticals Inc Liquidity Ratios

Ionis Pharmaceuticals Inc Asset Efficiency Ratios

Ionis Pharmaceuticals Inc Liability Ratios

Ionis Pharmaceuticals Inc Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Company

Explore Products

Popular US Stocks ¹

Popular US ETFs ²

Curated Portfolios (Vests)

Risk Disclosure - US Markets

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

Ionis Pharmaceuticals Inc Share Price

Ionis Pharmaceuticals Inc Analyst Forecast

Ionis Pharmaceuticals Inc Share Price Chart

Ionis Pharmaceuticals Inc Key Stock Metrics

About Ionis Pharmaceuticals Inc, Common Stock

Ionis Pharmaceuticals Inc Stock Returns

Ionis Pharmaceuticals Inc Financials

Ionis Pharmaceuticals Inc Ratios

Ionis Pharmaceuticals Inc Liquidity Ratios

Ionis Pharmaceuticals Inc Asset Efficiency Ratios

Ionis Pharmaceuticals Inc Liability Ratios

Ionis Pharmaceuticals Inc Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Popular US Stocks 1

Popular US ETFs 2

Curated Portfolios (Vests)

Popular US Stocks ¹

Popular US ETFs ²